HUDSON PACIFIC PROPERTIES IN (HPP)

US4440971095 - REIT

3.03  0 (0%)

Fundamental Rating

1

Taking everything into account, HPP scores 1 out of 10 in our fundamental rating. HPP was compared to 129 industry peers in the Diversified REITs industry. HPP may be in some trouble as it scores bad on both profitability and health. HPP is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year HPP has reported negative net income.
In the past year HPP had a positive cash flow from operations.
In multiple years HPP reported negative net income over the last 5 years.
In the past 5 years HPP always reported a positive cash flow from operatings.

1.2 Ratios

HPP has a worse Return On Assets (-3.55%) than 84.13% of its industry peers.
Looking at the Return On Equity, with a value of -9.75%, HPP is doing worse than 81.75% of the companies in the same industry.
Industry RankSector Rank
ROA -3.55%
ROE -9.75%
ROIC N/A
ROA(3y)-0.95%
ROA(5y)-0.46%
ROE(3y)-2.6%
ROE(5y)-1.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HPP's Operating Margin has declined in the last couple of years.
HPP has a worse Gross Margin (46.99%) than 81.75% of its industry peers.
In the last couple of years the Gross Margin of HPP has declined.
HPP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.99%
OM growth 3Y-42.29%
OM growth 5Y-31.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.66%
GM growth 5Y-3.58%

1

2. Health

2.1 Basic Checks

HPP does not have a ROIC to compare to the WACC, probably because it is not profitable.
HPP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, HPP has less shares outstanding
Compared to 1 year ago, HPP has an improved debt to assets ratio.

2.2 Solvency

A Debt/Equity ratio of 1.39 is on the high side and indicates that HPP has dependencies on debt financing.
HPP's Debt to Equity ratio of 1.39 is in line compared to the rest of the industry. HPP outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC4.73%

2.3 Liquidity

HPP has a Current Ratio of 0.47. This is a bad value and indicates that HPP is not financially healthy enough and could expect problems in meeting its short term obligations.
HPP's Current ratio of 0.47 is on the low side compared to the rest of the industry. HPP is outperformed by 90.48% of its industry peers.
A Quick Ratio of 0.47 indicates that HPP may have some problems paying its short term obligations.
The Quick ratio of HPP (0.47) is worse than 86.51% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47

1

3. Growth

3.1 Past

HPP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.63%.
The Revenue for HPP has decreased by -14.31% in the past year. This is quite bad
The Revenue has been growing slightly by 5.51% on average over the past years.
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.26%
Revenue 1Y (TTM)-14.31%
Revenue growth 3Y5.76%
Revenue growth 5Y5.51%
Sales Q2Q%-13.42%

3.2 Future

HPP is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -26.26% yearly.
HPP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.87% yearly.
EPS Next Y-125.09%
EPS Next 2Y-46.79%
EPS Next 3Y-26.26%
EPS Next 5YN/A
Revenue Next Year-11.48%
Revenue Next 2Y-5.94%
Revenue Next 3Y-1.85%
Revenue Next 5Y3.87%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

HPP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year HPP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HPP.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.09

4.3 Compensation for Growth

A cheap valuation may be justified as HPP's earnings are expected to decrease with -26.26% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-46.79%
EPS Next 3Y-26.26%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.60%, HPP is a good candidate for dividend investing.
In the last 3 months the price of HPP has falen by -35.26%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
HPP's Dividend Yield is a higher than the industry average which is at 15.86.
Compared to an average S&P500 Dividend Yield of 2.30, HPP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.6%

5.2 History

The dividend of HPP decreases each year by -11.99%.
HPP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-11.99%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

HPP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The Dividend Rate of HPP has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-12.19%
EPS Next 2Y-46.79%
EPS Next 3Y-26.26%

HUDSON PACIFIC PROPERTIES IN

NYSE:HPP (1/2/2025, 9:48:57 AM)

3.03

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)02-10 2025-02-10/amc
Inst Owners110.23%
Inst Owner Change0.69%
Ins Owners2.9%
Ins Owner Change2.94%
Market Cap427.93M
Analysts54.74
Price Target5.03 (66.01%)
Short Float %19.91%
Short Ratio6.3
Dividend
Industry RankSector Rank
Dividend Yield 6.6%
Dividend Growth(5Y)-11.99%
DP-12.19%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.17%
Min EPS beat(2)-12.04%
Max EPS beat(2)11.69%
EPS beat(4)3
Avg EPS beat(4)28.24%
Min EPS beat(4)-12.04%
Max EPS beat(4)92.38%
EPS beat(8)6
Avg EPS beat(8)-116.82%
EPS beat(12)7
Avg EPS beat(12)-435.51%
EPS beat(16)9
Avg EPS beat(16)-319.7%
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-4.79%
Max Revenue beat(2)-0.4%
Revenue beat(4)0
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-4.79%
Max Revenue beat(4)-0.4%
Revenue beat(8)1
Avg Revenue beat(8)-1.35%
Revenue beat(12)5
Avg Revenue beat(12)0.11%
Revenue beat(16)9
Avg Revenue beat(16)1.29%
PT rev (1m)-8.13%
PT rev (3m)-14.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-69.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.31%
Revenue NY rev (1m)-0.51%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.5
P/FCF N/A
P/OCF 2.46
P/B 0.14
P/tB 0.15
EV/EBITDA 14.09
EPS(TTM)-1.16
EYN/A
EPS(NY)-1.51
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)1.23
OCFY40.6%
SpS6.06
BVpS21.44
TBVpS19.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.55%
ROE -9.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.99%
FCFM N/A
ROA(3y)-0.95%
ROA(5y)-0.46%
ROE(3y)-2.6%
ROE(5y)-1.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.33%
ROCE(5y)1.6%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-42.29%
OM growth 5Y-31.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.66%
GM growth 5Y-3.58%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF N/A
Debt/EBITDA 13.05
Cap/Depr 62.29%
Cap/Sales 26.82%
Interest Coverage N/A
Cash Conversion 53.9%
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z N/A
F-Score2
WACC4.73%
ROIC/WACCN/A
Cap/Depr(3y)108.81%
Cap/Depr(5y)159.35%
Cap/Sales(3y)41.87%
Cap/Sales(5y)59.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-59.26%
EPS Next Y-125.09%
EPS Next 2Y-46.79%
EPS Next 3Y-26.26%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.31%
Revenue growth 3Y5.76%
Revenue growth 5Y5.51%
Sales Q2Q%-13.42%
Revenue Next Year-11.48%
Revenue Next 2Y-5.94%
Revenue Next 3Y-1.85%
Revenue Next 5Y3.87%
EBIT growth 1Y-155.36%
EBIT growth 3Y-38.97%
EBIT growth 5Y-27.87%
EBIT Next Year498.17%
EBIT Next 3Y91.97%
EBIT Next 5Y76.11%
FCF growth 1Y57.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.45%
OCF growth 3Y-8.38%
OCF growth 5Y1.59%